PORTER CABLE® announces the launch of its 20V MAX* Lithium Ion Brushless Drill/Driver (PCCK607LB) and 20V MAX* Lithium Ion Brushless Impact Driver (PCCK647LB), which are both part of the new Brushless EDGE™ family of tools. The 20V MAX* Lithium Ion Brushless Drill/Driver and 20V MAX* Lithium Ion Brushless Impact Driver are extensions to the 20V MAX* Get Linked System® tools, a range of professional cordless core tools at a great price. These two tools operate on any PORTER CABLE 20V MAX* Lithium Ion battery. Integrating brushless motor technology for the first time in its system of tools, these two new PORTER CABLE brushless products offer up to 50% more runtime** to minimize downtime on the jobsite.
The 20V MAX* Lithium Ion Brushless Drill/Driver (PCCK607LB) boasts more runtime as well as 20% more power and improved bit retention compared to the prior model (PCC601). Its efficient brushless motor, high-speed transmission, and 1.5Ah battery deliver up to 370 Max Watts Out (MWO) to maximize drilling and fastening speeds. A two-speed gear transmission delivers 0-450 Rotations Per Minute (RPM) in low speed for high-torque applications and 0-1,800 RPM in high speed for maximum fastening speed. Since compact size is an important feature for professionals, the 20V MAX* Lithium Ion Brushless Drill/Driver is just 7.4 inches in length and weighs only 3.3 pounds with its battery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7517856-porter-cable-announces-brushless-edge/
Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV).
CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
As part of a yearlong 75th anniversary celebration, Crowe CEO Jim Powers challenged personnel to volunteer 75,000 hours in their communities, more than double the number of volunteer hours from the previous year.
“Not only did our people meet the 75,000-hour challenge, they crushed it,” said Powers. “By the end of the challenge, we volunteered 82,000 hours, the equivalent of providing 39 full-time people at the nonprofits we served.” Two-thirds of personnel volunteered during the year, well above the industry norm of 31 percent. Using data from Independent Sector, the volunteer hours translate to an economic impact of more than $2 million for the nonprofits.
To view the multimedia release go to:
https://www.multivu.com/players/English/8368851-crowe-personnel-volunteer-75000-hours/
United Way and the Ad Council, in collaboration with the National Football League, have announced an extension of their successful LIVE UNITED campaign, including a new series of public service ads (PSAs) featuring NFL players promoting health and wellness, and ads showcasing the true outcome of United Way’s work in local communities. The new campaign also includes an online interactive map that illustrates local impact stories from United Ways around the country.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7301351-ad-council-united-way-nfl-extend-live-united-campaign-health-wellness-psas/
As entrepreneurs struggle to find desirable investments that also allow them to have an impact on the future of our country, Primrose Schools invites them to explore the benefits of opening a high-quality Primrose preschool in their communities. As the nation’s leading early education franchise company, Primrose currently has more than 350 locations in 29 states and is growing across the country.
Financial forecasters and economic developers alike point to early education as a stable investment that yields strong returns. A recent report by Child Care Aware shows that the high-quality early education industry generates a return of more than $8 for every $1 spent, meaning the returns of providing early education for children positively impact the economic development of communities and future workforce development. Last year, IBIS World reported that the industry reached a record high of $47.8 billion and is expected to continue to grow at an even faster pace than the overall child services market.
To view the multimedia release go to:
https://www.multivu.com/players/English/8014454-primrose-schools-open-your-own-school/
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
International automakers today are highlighting their investment and dedication to the U.S. auto industry with the launch of Here For America. This new initiative provides a platform for international automakers to share the story of their ever growing impact on the U.S. economy and the benefits they provide to local communities.
“Today’s U.S. auto industry is diverse, vibrant, competitive and global,” said John Bozzella, president and CEO of Global Automakers and spokesman for Here For America. “From the lab to the lot, international automakers are producing high-quality vehicles for consumers here in America and around the globe using local workers and local resources to invigorate local communities.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7223353-global-automakers-here-for-america/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
A Harvard School of Dental Medicine symposium recently featured data from United Concordia Dental’s landmark study as compelling evidence on the costly impact of poor oral health on overall wellness.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7052551-united-concordia-dental-research-featured-at-harvard-university-symposium/
ConnXus, a supplier diversity technology platform, today announced that it has closed $5 million in Series “A” funding, led by Techstars Ventures, Serious Change L.P. and Impact America Fund.
“This round of funding will significantly accelerate ConnXus’ long-term impact on generating sustainable and diverse supply chains,” said Rod Robinson, CEO and founder of ConnXus. “To date we’ve raised $10 million in investments, including participation from Techstars Ventures, CincyTech, Serious Change L.P., Impact America Fund, and several private angel investors.”
ConnXus’ cloud-based, supplier diversity sustainability dashboards open the door for procurement, supplier diversity, and supply chain professionals to access a wealth of global supply chain analytics. Robinson believes Techstars and the other investors are the right investors for the company to disrupt and add imperative value to the $10-billion supply chain and procurement software market.
To view the multimedia release go to:
http://www.multivu.com/players/English/7834951-connxus-five-million-series-a/
Global specialty plastics provider Eastman demonstrates the dominant performance of next-generation material Eastman MXF221 copolyester as a disinfectant-ready polymer for safer healthcare environments at the Medical Design & Manufacturing (MD&M) West trade show in Anaheim, California, Feb. 6 to 8. The latest advancement in biocompatible medical-grade polymers for medical device housings and hardware, Eastman MXF221 offers unsurpassed chemical compatibility with stringent disinfectants used to combat healthcare-associated infections (HAIs) as well as improved durability and impact strength.
To view the multimedia release go to:
https://www.multivu.com/players/English/8261151-eastman-disinfectant-ready-polymer-mdm-west/
Medical, health, technology, healthcare, treatment, Richard Fechter, interview, trade show, MultiVu 8261151
